Marina Pipeline on Track with FAP Trial in 2010, But Could Miss Partnership Guidance
November 18, 2010
Marina Pipeline on Track with FAP Trial in 2010, But Could Miss Partnership Guidance
The company's vice president of corporate development said that Marina is "committed" to signing two partnerships before year end, but indicated that it may miss this goal if the terms of the deals aren't right.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Marina Biotech Advances FAP Drug into Phase I
March 17, 2011 / Gene Silencing News - Debiopharm Drops Out of Bladder Cancer Deal with Cash-Strapped Marina
November 15, 2012 / Gene Silencing News - Marina Preps for Additional Patient Enrollment in FAP Trial, Predicts Pharma Partnership This Year
January 26, 2012 / Gene Silencing News - Marina Aims for Industry Partnership in 2012, Posts Lower Q3 Losses
November 10, 2011 / Gene Silencing News - Marina Publishes Data from Bladder Cancer Program Showing 'Significant' Tumor Reduction with UsiRNAs
March 10, 2011 / Gene Silencing News